RDEA Financial Facts
Reimbursable research and development costs: 326KSponsored research: 73K
See Full Income Statement
Short-term investments, available-for-sale: 124.2M
Accrued payroll and employee liabilities: 2.6M
See Full Balance Sheet
Ardea Biosciences, Inc. (RDEA) Earnings
|
Expand Research on RDEA
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -29.4% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -6.7% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/7/12 | Q112 | -$1.25 | -$0.98 | -$0.27 | $1.5M | $3M | N/A | Details | |||
3/9/12 | Q411 | -$1.15 | -$0.86 | -$0.29 | $1.7M | $1.85M | N/A | Details | |||
11/4/11 | Q311 | -$0.84 | -$0.67 | -$0.17 | $1.7M | $1.95M | N/A | Details | |||
8/5/11 | Q211 | -$0.68 | -$0.52 | -$0.16 | $2.2M | $2.69M | N/A | Details | |||
5/6/11 | Q111 | -$0.59 | -$0.50 | -$0.09 | $1.77M | $3.86M | N/A | Details | |||
3/11/11 | Q410 | -$0.03 | -$0.59 | +$0.56 | $17.3M | $4.04M | N/A | Details |